Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest update is out from Vincent Medical Holdings Limited ( (HK:1612) ).
Vincent Medical Holdings Limited has declared a final ordinary cash dividend of HK$0.026 per share for the financial year ended 31 December 2025, subject to shareholder approval at a meeting scheduled for 20 May 2026. The dividend, payable in Hong Kong dollars, will go ex-dividend on 26 May 2026, with the record date set for 1 June 2026 and payment to shareholders scheduled for 18 June 2026.
The announcement outlines the key timetable for investors, including the last time to lodge share transfers on 27 May 2026 and a book closure period from 28 May to 1 June 2026, while confirming that no withholding tax or related warrant or convertible security adjustments apply to this distribution. The move signals the company’s intention to return cash to shareholders based on its 2025 performance, offering income visibility and clarity on capital returns without additional tax complications noted in the disclosure.
The most recent analyst rating on (HK:1612) stock is a Buy with a HK$1.00 price target. To see the full list of analyst forecasts on Vincent Medical Holdings Limited stock, see the HK:1612 Stock Forecast page.
More about Vincent Medical Holdings Limited
Vincent Medical Holdings Limited is a Hong Kong-listed company in the medical sector, though the announcement does not specify its exact product lines or markets. The group is listed under stock code 01612 on the Stock Exchange of Hong Kong and has a board comprising executive, non-executive and independent non-executive directors, reflecting a standard corporate governance structure for a mid-cap issuer.
Average Trading Volume: 904,687
Technical Sentiment Signal: Buy
Current Market Cap: HK$586.7M
Learn more about 1612 stock on TipRanks’ Stock Analysis page.